Smith Group Asset Management’s GSK GSK Stock Holding History

Smith Group Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-11,760	Closed	-$597K	–	452
2017 Q3	$597K	Hold	11,760	–	–	0.02%	204
2017 Q2	$634K	Buy	11,760 +8,283	+238%	+$442K	0.02%	192
2017 Q1	$183K	Sell	3,477 -160	-4%	-$8.12K	0.01%	280
2016 Q4	$175K	Sell	3,637 -80	-2%	-$3.95K	0.01%	267
2016 Q3	$200K	Hold	3,717	–	–	0.01%	254
2016 Q2	$201K	Sell	3,717 -320	-8%	-$16.9K	0.01%	262
2016 Q1	$205K	Buy	+4,037	New	+$201K	0.01%	217

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Smith Group Asset Management's GSK Position: Q4 2017 in Review

Smith Group Asset Management sold out of GSK (GSK) in Q4 2017, closing a stake of 11,760 shares — an estimated $597K sold.

Smith Group Asset Management first reported a position in GSK in Q1 2016 and held it in 7 quarters. The position peaked at $634K in Q2 2017. 763 funds tracked by Wall St. Rank hold GSK as of Q4 2017.

Smith Group Asset Management reported no remaining GSK position as of Q4 2017 after selling out during the quarter.
Smith Group Asset Management sold 11,760 GSK shares in Q4 2017, an estimated $597K.
Smith Group Asset Management first reported a position in GSK in Q1 2016 and held it in 7 quarters.
Smith Group Asset Management's GSK position peaked at $634K in Q2 2017.
763 funds tracked by Wall St. Rank held GSK as of Q4 2017.

Based on Smith Group Asset Management's 13F filing for Q4 2017, filed 12 Feb 2018.